首页> 外国专利> ANTI-TUMOR DRUG DELIVERY SYSTEMS OF TERNARY BIOMOLECULAR NANOPARTICLES OF FOLATE RECEPTOR CONJUGATED HEPARIN

ANTI-TUMOR DRUG DELIVERY SYSTEMS OF TERNARY BIOMOLECULAR NANOPARTICLES OF FOLATE RECEPTOR CONJUGATED HEPARIN

机译:叶酸共轭肝素三元生物纳米颗粒的抗肿瘤药物输送系统

摘要

PURPOSE: drug delivery system for the antitumor conjugation with ternary biomolecule of anticancer be configured to support and release anticancer with heparin or anticarcinogen is without side-effects. ;CONSTITUTION: it includes that ternary biomolecule contains heparin, aminized folic acid, and is compounded with anticancer or anti-tumor activity that drug delivery system is antitumor for anticancer. The structure of heparin has hydroxyl (- OH), carboxyl (- COOH), amino (- NH_2). The compound has anticancer or anti-tumor activity (- COOH) includes carboxyl or amino (- NH_2). The compount with creditors is retinoic acid, taxol, doxetaxel, vincristine, vinorelbine. ;The 2011 of copyright KIPO submissions
机译:目的:用于与抗癌三元生物分子结合的抗肿瘤药物输送系统,经配置可与肝素或抗癌药一起支持和释放抗癌药,且无副作用。组成:该三元生物分子包含肝素,胺化叶酸,并具有抗癌或抗肿瘤活性,药物递送系统具有抗癌作用。肝素的结构具有羟基(-OH),羧基(-COOH),氨基(-NH_2)。具有抗癌或抗肿瘤活性的化合物(-COOH)包括羧基或氨基(-NH_2)。债权人的成分是视黄酸,紫杉醇,多西他赛,长春新碱,长春瑞滨。 ; 2011年版权KIPO提交文件

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号